Comparison of Low Volume PEG-Asc and Lower Volume PEG-Asc With Bisacodyl
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
Recently a low-volume polyethylene glycol containing ascorbic acid (PEG-Asc) formulation has
proven as safe and effective as traditional 4-L PEG solutions for colonoscopy preparation.
However, currently available aqueous purgative formulations are poorly tolerated. The aim of
this study was to compare a split-dose 2-L PEG-Asc and a 1-L PEG-Asc with bisacodyl (10 mg)
formulation to determine the quality of bowel cleansing and patient tolerability.